Börset M - Search Results

1

Comparison of the effects of 2-chlorodeoxyadenosine and melphalan myeloma cell lines.

Hjertner O, Börset M, Waage A. Hjertner O, et al. Among authors: borset m. Leuk Res. 1996 Feb;20(2):155-60. doi: 10.1016/0145-2126(95)00128-x. Leuk Res. 1996. PMID: 8628014

2

TNF and IL-6 are potent growth factors for OH-2, a novel human myeloma cell line.

Börset M, Waage A, Brekke OL, Helseth E. Börset M, et al. Eur J Haematol. 1994 Jul;53(1):31-7. doi: 10.1111/j.1600-0609.1994.tb00176.x. Eur J Haematol. 1994. PMID: 8062895

3

Lack of IL-1 secretion from human myeloma cells highly purified by immunomagnetic separation.

Borset M, Helseth E, Naume B, Waage A. Borset M, et al. Br J Haematol. 1993 Nov;85(3):446-51. doi: 10.1111/j.1365-2141.1993.tb03331.x. Br J Haematol. 1993. PMID: 8136264

4

Hepatocyte growth factor reverses the TGF-beta-induced growth inhibition of CCL-64 cells. A novel bioassay for HGF and implications for the TGF-beta bioassay.

Börset M, Waage A, Sundan A. Börset M, et al. J Immunol Methods. 1996 Jan 16;189(1):59-64. doi: 10.1016/0022-1759(95)00228-6. J Immunol Methods. 1996. PMID: 8576580

5

Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell lines.

Borset M, Lien E, Espevik T, Helseth E, Waage A, Sundan A. Borset M, et al. J Biol Chem. 1996 Oct 4;271(40):24655-61. doi: 10.1074/jbc.271.40.24655. J Biol Chem. 1996. PMID: 8798732 Free article.

6

The role of the two TNF receptors in proliferation, NF-kappa B activation and discrimination between TNF and LT alpha signalling in the human myeloma cell line OH-2.

Börset M, Medvedev AE, Sundan A, Espevik T. Börset M, et al. Cytokine. 1996 Jun;8(6):430-8. doi: 10.1006/cyto.1996.0059. Cytokine. 1996. PMID: 8818539

7

Hepatocyte growth factor and its receptor c-met in multiple myeloma.

Börset M, Hjorth-Hansen H, Seidel C, Sundan A, Waage A. Börset M, et al. Blood. 1996 Nov 15;88(10):3998-4004. Blood. 1996. PMID: 8916966 Free article.

8

Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group.

Seidel C, Børset M, Turesson I, Abildgaard N, Sundan A, Waage A. Seidel C, et al. Among authors: borset m. Blood. 1998 Feb 1;91(3):806-12. Blood. 1998. PMID: 9446640 Free article.

9

Role of hepatocyte growth factor and its receptor c-met in multiple myeloma.

Seidel C, Børset M, Hjorth-Hansen H, Sundan A, Waage A. Seidel C, et al. Among authors: borset m. Med Oncol. 1998 Sep;15(3):145-53. doi: 10.1007/BF02821933. Med Oncol. 1998. PMID: 9819791 Review.

10

Marked osteoblastopenia and reduced bone formation in a model of multiple myeloma bone disease in severe combined immunodeficiency mice.

Hjorth-Hansen H, Seifert MF, Börset M, Aarset H, Ostlie A, Sundan A, Waage A. Hjorth-Hansen H, et al. Among authors: borset m. J Bone Miner Res. 1999 Feb;14(2):256-63. doi: 10.1359/jbmr.1999.14.2.256. J Bone Miner Res. 1999. PMID: 9933480 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters